Not Signed In - European Union's CHMP Adopts Positive Opinion For NOXAFIL(R) (posaconazole) Oral Suspension For Prevention Of Invasive Fungal Infections
Sat, 23 Sep 2006 07:00 AM EST
... Schering-Plough Corporation (NYSE: SGP) today reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending approval of NOXAFIL(R) (posaconazole) Oral Suspension for prophylaxis (prevention) of invasive fu [click link for full article] ...
Related Topics
- Fungal Infections
- Fungal Infections & Diseases
- Amoxicillin Oral Suspension
- Fungal Diseases
- Aluminum and Magnesium Hydroxide Oral Suspension
- Erythromycin Oral Suspension
- Megestrol Oral Suspension
- Tetracycline Oral Suspension
- Griseofulvin Oral Suspension
- Azithromycin Oral Suspension
- Nystatin Oral Suspension
- Famotidine Oral Suspension
- Rofecoxib Oral Suspension
- Sulfisoxazole Oral Suspension or Syrup
- Injury/ Injury Prevention
- Furazolindone Oral Suspension
- Acyclovir Oral Suspension
- Sucralfate Oral Suspension
- Diazoxide Oral Suspension
- Ampicillin Oral Suspension
email this page
print this page
bookmark this page
feedback on this page
